Non-small Cell Lung Cancer With EGFR-Activating Mutations

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11963Dacomitinib3Completed1
DB00317Gefitinib3Completed1